These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 8903054
1. Is a combination of verapamil and an ACE-inhibitor the optimal solution in ischaemic heart failure? Jespersen CM. Cardiologia; 1995 Dec; 40(12 Suppl 1):307-10. PubMed ID: 8903054 [No Abstract] [Full Text] [Related]
2. Congestive heart failure and ischaemic heart disease treated with trandolapril and verapamil. DAVIT Study Group. Danish Verapamil Infarction Trial. Hansen JF. J Hypertens Suppl; 1998 Jan; 16(1):S71-4. PubMed ID: 9534101 [Abstract] [Full Text] [Related]
3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [Abstract] [Full Text] [Related]
4. [Evolution of myocardial ischemia therapy: calcium antagonists and ACE-inhibitors]. Ferrari R. Cardiologia; 1994 Dec; 39(12 Suppl 1):203-6. PubMed ID: 7634268 [Abstract] [Full Text] [Related]
5. Fixed low-dose combination of an angiotensin converting enzyme inhibitor and a calcium channel blocker drug in the treatment of essential hypertension. de Leeuw PW, Kroon AA. J Hypertens Suppl; 1997 Mar; 15(2):S39-42. PubMed ID: 9218197 [Abstract] [Full Text] [Related]
6. [Combination therapy in primary hypertension]. Halawa B. Pol Merkur Lekarski; 1998 Jan; 4(19):35-8. PubMed ID: 9553408 [Abstract] [Full Text] [Related]
7. Angiotensin converting enzyme inhibitor-calcium antagonist combination: an alliance for cardioprotection? Ferrari R. J Hypertens Suppl; 1997 Mar; 15(2):S109-17. PubMed ID: 9218207 [Abstract] [Full Text] [Related]
8. [The application of 4-aminopyridine in calcium channel inhibitors acute poisoning]. Fiszer M, Kołaciński Z, Rechciński T. Przegl Lek; 2007 Mar; 64(4-5):293-7. PubMed ID: 17724889 [Abstract] [Full Text] [Related]
9. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). McMurray J, Solomon S, Pieper K, Reed S, Rouleau J, Velazquez E, White H, Howlett J, Swedberg K, Maggioni A, Køber L, Van de Werf F, Califf R, Pfeffer M. J Am Coll Cardiol; 2006 Feb 21; 47(4):726-33. PubMed ID: 16487836 [Abstract] [Full Text] [Related]
10. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials. Tokmakova M, Solomon SD. Curr Opin Cardiol; 2006 Jul 21; 21(4):268-72. PubMed ID: 16755193 [Abstract] [Full Text] [Related]
11. [Incidence of arrhythmias in acute myocardial infarct treated with verapamil, digitalis and a verapamil-digitalis combination]. De Lio U, Maiolino P, Trevisan G, Cappelletti F, Vincenzi M. Boll Soc Ital Cardiol; 1981 Jul 21; 26(9):857-65. PubMed ID: 7347268 [No Abstract] [Full Text] [Related]